Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NGM list the first exchange traded product on Litecoin and XRP

At the end of this week XBT Provider will list exchange traded products with Litecoin and XRP as underlying assets at NGM. Litecoin will start trading as of April 4 and XRP as of April 5, 2019.“This is first and foremost a win for investors, especially those in Sweden who have demonstrated such strong support of prior crypto offerings. As an industry, it is important for us to listen, though with caution, to the requests of our investors and respond in kind. We are very excited to be part of making history here with the first ever LTC and XRP tracking products; and look forward to

Aker ASA: Notice of Annual General Meeting

The Annual General Meeting of Aker ASA will be held on Friday 26 April 2019 at 10:00 CET, at Oksenøyveien 10, Building B, Grand Hall, 1366 Lysaker, Norway.Please find attached the following documents:   * The annual general meeting notice including attendance and proxy forms  * The board of directors' proposed resolutions  * Guidelines for remuneration of senior executives of the company  * Proposal from the nomination committee All the documents to be processed at the general meeting are available on the company's website www.akerasa.com . ENDS For further information,

RhoVac submits application for the start of clinical phase IIb study with the drug candidate RV001

RhoVac AB ("RhoVac") announced today, 4th April 2019, that the company has submitted the application for clinical trial (CTA, Clinical Trial Application) to the Danish Medicines Agency (Laegemiddelstyrelsen) and to the Scientific Ethics Committee. The application is for a permit to start a clinical phase IIb study with the drug candidate RV001 in prostate cancer patients.The drug candidate RV001 is targeting early metastasis in cancer patients. The proposed study focuses on prostate cancer patients, who have completed primary treatment (prostatectomy or radiation therapy) and show

FlexQube´s annual report 2018 available on the website

FlexQube´s annual report 2018 has today been published on FlexQube´s website and can be downloaded at: https://issuu.com/flexqube/docs/flexqube-_rsredovisning_2018-hr_pag?e=0 The financial year covers the period from 1 January to 31 December 2018. The annual report will also be translated to English and is planned to be published before May 1st. About FlexQube FlexQube is a company that offers a unique and patented concept that is used to design and deliver robust, modular and flexible carts and racks. The company has manufacturing in Sweden and USA and distribution in North

Nordic Nanovector ASA: Notice of Annual General Meeting on 25 April 2019

Notice is given that the Annual General Meeting of Nordic Nanovector ASA will be held on 25 April 2019 at 15.00 hours CEST at Thon Hotel Vika Atrium, Munkedamsveien 45 in Oslo. The full notice with appendices and the recommendation from the Nomination Committee are attached. The notice and the documents to which it refers are also available on www.nordicnanovector.com. Shareholders wishing to attend the Annual General Meeting, in person or by proxy, must complete and return the attendance form or power of attorney form attached to the notice to Nordea Bank Abp, Issuer Service, Postboks

New Japanese patent approval for Episurf Medical

The Japanese patent office JPO has announced its intention to grant another Japanese patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “Design method of a rig”, is within the area of individualised surgical instruments with a focus on the drill guide for the Episealer® Femoral Twin implant. “This patent gives protection within the area of surgical guide instruments, and we are happy to strengthen our technology globally”, comments Katarina Flodström, CRO & Head of IP, Episurf Medical. For more  information, please contact: Pål Ryfors, CEO, Episurf MedicalTel:+46 (

Scandic’s Nomination Committee announces proposal for two new Board members

Prior to Scandic Hotels Group AB’s Annual General Meeting, the Nomination Committee has today announced that it will propose that Susanne Mørch Koch and Riitta Savonlahti be elected as new members of the Board of Directors. At the same time, it also announced that Lottie Knutson and Eva Moen Adolfsson will not stand for re-election. -  The proposal of Susanne Mørch Koch and Riitta Savonlahti ensures Board representation from Denmark and Finland, two important markets for Scandic. Susanne will contribute knowledge of driving digitalization and digital transformation in the transport and

Klarna launches global customer authentication platform

April 4, 2019 — Klarna, a leading global payments provider, today announced the launch of its global authentication platform — an aggregator with multiple global and local authentication solutions. The platform allows multinational businesses, including merchants and other banks, to provide a simple, secure and personalised customer authentication experience irrespective of market, through a one-time integration.Klarna has enabled millions of customers globally to shop securely without compromising their experience through an inhouse-developed customer authentication platform. This platform

Read original

New US patent approval for Episurf Medical

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “System and method for optimizing an implant in an anatomical joint”, covers parts of Episurf Medical’s technology for optimised design of the individualised Episealer® implants. This is the first approval in this patent family. "The Episealer® technology includes a number of details for optimised and efficient implant design, and this patent covers an important part thereof”, comments Katarina Flodström, CRO & Head of IP, Episurf

Changes in Handelsbanken’s management

Handelsbanken has today formed a new Executive Management team, consisting of the following executives:  Carina Åkerström, President and Group Chief Executive.Rolf Marquart, Chief Financial Officer. Rolf Marquart is also the Bank’s CFO at present.Per Beckman, Chief Credit Officer. Per Beckman is also the Bank’s CCO at present.Dan Lindwall, Head of Handelsbanken Capital Markets. Dan Lindwall is also Head of Handelsbanken Capital Markets at present.Martin Wasteson, Chief Legal Officer. Martin Wasteson is also the Bank’s CLO at present.Magnus Ericson, HR. Magnus Ericson is

Notice of the annual general meeting of Scandic Hotels Group AB

The shareholders of Scandic Hotels Group AB (556703-1702) (“Scandic” or the “Company”) are hereby invited to participate in the annual general meeting to be held on Tuesday, May 7, 2019 at 11:00 at Vasateatern, Grand Central, Vasagatan 19, SE-111 20 Stockholm, Sweden. Registration commences at 10:00. Registration and notification Shareholders who wish to participate in the annual general meeting must · be recorded in the share register kept by Euroclear Sweden AB on Tuesday, April 30, 2019, and · give notice to the Company of their intent to participate not later than on

Hoist Finance’s annual reporting 2018 published

Hoist Finance’s Annual Report and the Pillar 3 report, are now published and available at Hoist Finance’s website . Hoist Finance operates in a growing and profitable market and the market was considerably more attractive in 2018. In 2018, Hoist Finance has achieved strong growth in portfolio acquisitions and broadening product and geographical spread, hence delivering the best financial performance to date. Higher returns and new regulation has stimulated supply. A new operating model has been implemented to become more effective and efficient. The

Satya Abadi Pharma to distribute Acetium® lozenge in Indonesia

Press release 4.4.2019 at 09.30 local time (EEST) Biohit Oyj and Satya Abadi Pharma have signed an agreement for the distribution of the Acetium lozenge in Indonesia. The effectiveness of Acetium® lozenge in smoking intervention has been evaluated in two clinical trials.[1- 2] If a lozenge is sucked every time a cigarette is smoked, eventually the taste of cigarettes changes and the pleasure of smoking decreases making it is easier to quit. CEO Semi Korpela, Biohit Oyj: “The Acetium® lozenge for smoking cessation is an innovation developed and manufactured in Finland. It contains L-

Mårten Skogö leaves Tobii’s Group Management and is proposed as new member of the Board of Directors

Tobii’s co-founder Mårten Skogö leaves his position at Tobii for an employment with Industrifonden. He thereby also leaves his position in the Group Management of Tobii. Mårten is concurrently proposed as new member of Tobii’s Board of Directors. Mårten Skogö was one of the founding partners of Tobii together with Henrik Eskilsson and John Elvesjö in 2001. Since then, Mårten has had several roles in the Company, for instance as manager within the Development organization and Chief Science Officer. – Mårten has been a key player during Tobii’s early phase and growth journey and his

Humana publishes Annual report 2018 and Sustainability report 2018

Today Humana publishes its Annual Report including the Sustainability Report for 2018.Humana's annual report 2018 is available at http://corporate.humana.se/en. It is also attached to this press release. This is information that Humana AB (publ) is obliged to publish in accordance with the Swedish Securities Market Act. The information was submitted for publication at 08.00 CET on 4 April 2019. For more information, please contact:Anna Sönne, Head of Investor Relations, +46 70 601 48 53, anna.sonne@humana.se

Notice to the Annual General Meeting 2019 in Eltel AB

The shareholders of Eltel AB (publ) (Reg. No. 556728-6652) (“Eltel”) are hereby invited to the Annual General Meeting to be held on Tuesday, 7 May 2019 at 14.00 CEST.Place Scandic Alvik, Gustavslundsvägen 135, 5th floor, 167 51 Bromma, Sweden. Notice of attendance Shareholders who wish to attend the Annual General Meeting shall: · be entered into the share register kept by Euroclear Sweden AB on Tuesday, 30 April 2019; and · give notice of his/her intention to participate at the Annual General Meeting no later than Tuesday, 30 April 2019, preferably by noon CEST. Notice

Pileseptin is now available for sale at Apotek Hjärtat

Double Bond Pharmaceuticals subsidiary Drugsson AB, distributor of Pileseptin in the Nordic market, reports that Pileseptin in both gel and spray form is now available at Apotek Hjärtat. Earlier this year the product became available at APOHEM, Apotea, Apotek365 and Meds.se in Sweden as well as on Webpharma in Norway. "We are happy to now have our first marketed non-prescription product in one of the largest pharmacy chains in Sweden and we continue to work towards establishing deals with other sales channels in the future," comments Igor Lokot, CEO at Double Bond Pharmaceutical and

Veidekke ASA: Sold homes for NOK 2.5 billion in Q1

Veidekke sold 404 residential units in the first quarter of 2019, which is twice as many as in the fourth quarter of 2018. The sales boost is driven by projects in Norway. Overall, Veidekke has sold homes for NOK 2.5 billion in Q1 2019. The number of units under construction is 2,808.Veidekke sold 404 residential units in the first quarter of 2019. In comparison, 152 homes were sold in Q1 2018 and 200 homes in Q4. Sales have been stable in Sweden, while they have increased in Norway. The value of the residential units sold was NOK 2,5 billion, and Veidekke’s share was NOK 1,6 billion.   “

Notice of the 2019 Annual General Meeting of Tobii

The shareholders in Tobii AB (publ) are hereby summoned to the annual general meeting on Thursday, 9 May 2019 at 5 p.m. at Bygget Fest & Konferens, Norrlandsgatan 11 in Stockholm. Notification etc.Shareholders who wish to participate in the annual general meeting must firstly  be included in the shareholders’ register maintained by Euroclear Sweden AB as of Friday, 3 May 2019, andsecondly  notify the company of their participation in the annual general meeting no later than on Friday, 3 May 2019. The notification shall be in writing to Tobii AB, Box 743, 182 17 Danderyd, Sweden,

Notice of Annual General Meeting in TF Bank AB (publ)

Shareholders of TF Bank AB (publ) are hereby notified of the Annual General Meeting.Time: Tuesday May 7, 2019, at 15.00 CET.Place: Roschier Advokatbyrå, Brunkebergstorg 2 in Stockholm. Shareholders are welcome from 14.30 CET. Light refreshments will be served before the meeting. In connection to the CEO's speech, there will be an opportunity for you as a shareholder to ask questions to the management of TF Bank. Registration etc.Shareholders who wish to attend the Annual General Meeting shall be recorded in the share register kept by Euroclear Sweden AB (”Euroclear”) on April 30,

Gränges enters into new credit facility agreements and increases the financial flexibility

Gränges has refinanced the credit agreement that originally financed the acquisition of the US business in August 2016. The new credit facilities give Gränges a cost-effective financing, an increased financial flexibility and a prolonged time to maturity. The new credit facilities consist of a revolving credit facility available in several currencies of SEK 2,000 million with a term of 3 years and an option to prolong to 5 years, a Term Loan of USD 100 million with a term of 5 years and a revolving credit facility for the American subsidiary Gränges Americas Inc. of USD 50 million with a

Loomis expands by acquiring Prosegur Cash in France

Loomis AB has, through a wholly owned subsidiary, entered into an agreement to acquire 100 percent of Prosegur Cash Holding France (PCF). PCF conducts primarily domestic cash handling services in France and has its head office in Lyon. The final purchase price will be determined on closing of the transaction. The closing date is expected to be in the third quarter, 2019, pending local works council procedures and approval by the French foreign investment regulator. The purchase price is payable on closing. PCF has approximately 630 employees and the annual net revenue in 2018 was

SBB has successfully completed a directed share issue raising gross proceeds of approximately SEK 600m

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.The Board of Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB” or the “Company”) has, based on the authorization given by the extraordinary general meeting on 5 November 2018 and in accordance with what the Company indicated in a press release on 3 April 2019, decided on a directed new issue of 19,422,377 shares of

Orkla ASA: Notice of Orkla's Annual General Meeting 2019

The Annual General Meeting of Orkla ASA will be held at Ingeniørenes Hus, Kronprinsensgate 17, Oslo, on Thursday 25 April 2019 at 3 p.m. Notice of attendance must be received no later than 3 p.m. (Norwegian time) on 23 April 2019. Attached you will find the notice to the General Meeting, including appendices. The Notice is posted electronically or by mail to all shareholders. To order a printed version of the appendices to the Notice, see www.orkla.com. Notice of the Annual General Meeting and other documents relating to items of business, as well as further information concerning

There are no items matching the current filter
There are no more items matching the current filter
Back to top